Clinical trial
Prospective Study of Tirapazamine Targeting in Cervical Cancer
NCT00493376 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study of Tirapazamine Targeting in Cervical Cancer
- Lead sponsor
- British Columbia Cancer Agency
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 31, 2007
- Completion date
- Not reported
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervix cancer